CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled / 60 target
Drug / intervention
Biological/Vaccine: Allogeneic HB-adMSCs +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04995081
NCT04995081Phase 2CompletedOn Track (1.0/mo)Completion was 8mo ago
CompareCT.gov

A Randomized, Double-Blind, Single Center, Phase 2, Efficacy and Safety Study of Allogeneic HB-adMSCs vs Placebo for the Treatment of Patients With Parkinson's Disease

Hope Biosciences Research Foundation·interventional·Posted Aug 6, 2021·Updated Jun 10, 2026

In Brief

A Phase 2 clinical trial evaluating Biological/Vaccine: Allogeneic HB-adMSCs and Placebo for Parkinson Disease. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This is a randomized, double-blind, single center, phase 2 study to assess efficacy and safety of multiple allogeneic HB-adMSCs vs Placebo for the treatment of Parkinson's disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20222023202420252026
First PostedAug 6, 2021
Enrollment StartJul 16, 2021
Primary CompletionOct 3, 2025
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 4.9 years ago

Arms & Interventions

Allogeneic HB-adMSCs.active_comparator

Biological/Vaccine: Allogeneic HB-adMSCs Allogeneic HB-adMSCs will be administered intravenously to study participants who qualify. Other Names: Allogeneic Hope Biosciences adipose derived mesenchymal stem cells.

Biological: Biological/Vaccine: Allogeneic HB-adMSCsOther: Placebo
Placeboplacebo_comparator

Placebo will be administered intravenously to study participants who qualify. Other Names: Sterile Saline Solution 0.9%

Biological: Biological/Vaccine: Allogeneic HB-adMSCsOther: Placebo

Interventions

Biological/Vaccine: Allogeneic HB-adMSCsbiological

HB-adMSCs will be administered intravenously to study participants who qualify.

Placeboother

Sterile Saline Solution 0.9%